Cost-effectiveness of Down syndrome screening paradigms

Area of Science:

• Prenatal diagnosis
• Medical ethics
• Health economics

Background:

• Methodologic and ethical considerations in prenatal diagnosis are complex.
• Concerns include impacts on non-patients, assumptions about pregnancy termination, and redundancy of testing.
• Quantifying patient anxiety and experience related to screening results is challenging.

Purpose of the Study:

• To evaluate the cost-effectiveness of prenatal screening for Down syndrome (DS).
• To highlight the importance of understanding cost-effectiveness analysis in prenatal diagnosis.

Main Methods:

• Review of existing studies on the cost-effectiveness of Down syndrome screening.
• Analysis of current test characteristics and clinical situations.

Main Results:

• Prenatal screening for Down syndrome is cost-effective across various clinical scenarios.
• Contingent screening emerges as a potentially dominant strategy, offering lower costs and better outcomes.
• Current test performance supports the economic viability of DS screening.

Conclusions:

• Cost-effectiveness analysis is crucial for interpreting studies in prenatal diagnosis.
• Researchers, editors, and clinicians must understand these methodologies.
• Effective prenatal screening strategies, like contingent screening, can be economically advantageous.